Ionis Pharmaceuticals, Inc(IONS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IONS Ionis Pharmaceuticals, Inc

休市中 12-27 16:00:00 EST

35.91

-0.42

-1.16%

盘后35.84

-0.07-0.19%

17:38 EST

最高36.96	最低35.88	成交量100.46万
今开36.51	昨收36.33	日振幅2.97%
总市值56.70亿	流通市值56.25亿	总股本1.58亿
成交额3,626万	换手率0.64%	流通股本1.57亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IONS","market":"US","secType":"STK","nameCN":"Ionis Pharmaceuticals, Inc","latestPrice":35.91,"timestamp":1735333200000,"preClose":36.33,"halted":0,"volume":1004579,"hourTrading":{"tag":"盘后","latestPrice":35.84,"preClose":35.91,"latestTime":"17:38 EST","volume":45623,"amount":1637477.146,"timestamp":1735339106546},"delay":0,"floatShares":156649961,"shares":157897287,"eps":-2.458817,"marketStatus":"休市中","change":-0.42,"latestTime":"12-27 16:00:00 EST","open":36.51,"high":36.96,"low":35.88,"amount":36258563.184068,"amplitude":0.029727,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.458817,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1735549200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":36.33,"preHourTrading":{"tag":"盘前","latestPrice":36.58,"preClose":36.33,"latestTime":"09:29 EST","volume":1473,"amount":53591.753925000005,"timestamp":1735309799943},"postHourTrading":{"tag":"盘后","latestPrice":35.84,"preClose":35.91,"latestTime":"17:38 EST","volume":45623,"amount":1637477.146,"timestamp":1735339106546},"volumeRatio":0.5411075840976292,"impliedVol":0.2735,"impliedVolPercentile":0.0556},"requestUrl":"/m/hq/s/IONS/wiki","defaultTab":"wiki","newsList":[{"id":"2493781548","title":"美国研究综述-赫希、Paychex、Revvity","url":"https://stock-news.laohu8.com/highlight/detail?id=2493781548","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493781548?lang=zh_cn&edition=full","pubTime":"2024-12-23 15:07","pubTimestamp":1734937640,"startTime":"0","endTime":"0","summary":"美国研究综述-赫希、Paychex、Revvity路透12月23日 - 华尔街证券分析师周一调整了对包括好时、Paychex 和 Revvity 在内的几家美国上市公司的评级和目标价。要闻 * 好时HSY.N：杰富瑞将目标价从155美元下调至150美元 * Paychex Inc PAYX.O：贝尔德将目标价从139美元上调至143美元 * Revvity Inc RVTY.N：杰富瑞将目标价从125美元下调至120美元 * Vertex Pharmaceuticals Inc VRTX.O：丰业银行将目标价从426美元上调至430美元 * Winnebago Industries Inc WGO.N：杰富瑞将目标价从58美元下调至55美元以下是路透周一报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241223:nL4S3NO0D3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1430594728.SGD","BK4588","RVTY","GB00B4QBRK32.GBP","KNF","UNIT","VRTX","LW","IE00BJT1NW94.SGD","HSY","LU1035775433.USD","HK0000320264.USD","SJM","BK1141","AADI","BK4079","JLL","BK4139","VITL","MGPI","NBIX","01548","BGS","LU0114720955.EUR","LU0234570918.USD","LU0690374961.EUR","PAYX","IE00BZ9MQY76.HKD","LU0054578231.USD","FLO","IE00B19Z9Z06.USD","LU0417517546.SGD","SYK","PIPR","LEN","LU0109394709.USD","LU2089984988.USD","IE00BJJMRZ35.SGD","HALO","LU0128526141.USD","BK1576","REPL","IIPR","IONS","LEGN","BK4099","CVGW","LU0320765992.SGD","WGO","BK4567"],"gpt_icon":0},{"id":"2493270934","title":"BUZZ--美国股票走势-Spire、铜矿商、Abercrombie & Fitch","url":"https://stock-news.laohu8.com/highlight/detail?id=2493270934","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493270934?lang=zh_cn&edition=full","pubTime":"2024-12-21 02:41","pubTimestamp":1734720117,"startTime":"0","endTime":"0","summary":"        *      个股走势的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      新闻早报通讯：      12月20日 - 华尔街主要股指周五在震荡交投中跳涨，原因是一份冷于预期的通胀报告缓解了美联储预测2025年仅两次降息引发的一些市场担忧。美国东部时间13:30，道琼斯工业平均指数  上涨1.47%，报42963.15点；标普500指数  上涨1.36%，报5947.02点；纳斯达克综合指数  上涨1.34%，报19632.11点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CCL","HUMA","QID","FCX","PSQ","DDM","SIRI","SDOW","DXD","USAW.SI","SQQQ","NEM","GALT","AVO","TSYW.SI","LU1037948897.HKD",".IXIC","AADI","ISSC","MRK","SOL","GPCR","USJW.SI","AMGN","TQQQ","X","SNPS","NQmain","DJX","LU1934455194.USD",".DJI",".SPX","FDX","ALT","IONS","LU0719512351.SGD","APLM","MNQmain","SR","KMX","WGO","NVIW.SI","QLD","DOG","VKTX","SCCO"],"gpt_icon":1},{"id":"2492440770","title":"BUZZ--美国股票走势-Mission Produce、Sirius XM、嘉年华公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2492440770","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492440770?lang=zh_cn&edition=full","pubTime":"2024-12-20 23:39","pubTimestamp":1734709181,"startTime":"0","endTime":"0","summary":"        *      个股走势的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      12月20日 - 标普500指数和纳斯达克指数周五下跌，原因是市场担心明年的高利率问题，尽管一份冷于预期的通胀报告抑制了损失。美国东部时间10:30，道琼斯工业平均指数  上涨0.61%，报42601.62点。标普500指数  上涨0.49%，报5895.94点；纳斯达克综合指数  上涨0.44%，报19457.30点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["X","AMGN","PSQ","QLD","GALT","QID","CCL","KUKE","DNMR","NVIW.SI","XM","LLY","SQQQ","USAW.SI","TQQQ","NVO","DXD","WGO",".IXIC",".SPX","VNCE","GPCR","VKTX","DOG","MRK","NQmain","IONS","SOL","USJW.SI","DDM","SDOW","APLM","HUMA","IIPR","FDX","AADI","CLW","ALT",".DJI","DJX","SNPS","FDS","SIRI","AVO","KMX","TSYW.SI","MNQmain"],"gpt_icon":1},{"id":"2492449584","title":"BUZZ--美国股票走势-Humacyte、Ionis 制药公司、Emeren 集团","url":"https://stock-news.laohu8.com/highlight/detail?id=2492449584","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492449584?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:12","pubTimestamp":1734703974,"startTime":"0","endTime":"0","summary":"** 联邦快递FDX.N:BUZZ - 分析师认为联邦快递分拆货运部门是有益的；将PT升至 nL4N3NL0I5 。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nL4T3NL0VS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0310800965.SGD","AMGN","TSYW.SI","KMX","LU0823416689.USD","LU0061475181.USD","LU0348723411.USD","IE00BJLML261.HKD","ANSS","GALT","LU0256863902.USD","SOL","AADI","X","BK4133","LU0957791311.USD","SNPS","GPCR","ALT","LU0109392836.USD","LLY","LU0096364046.USD","SG9999015978.USD","IE00B4R5TH58.HKD","LU1988902786.USD","LU2458330169.SGD","LU0820561818.USD","LU1280957306.USD","APLM","LU1429558221.USD","SGXZ81514606.USD","LU0114720955.EUR","FDX","LU2458330243.SGD","LU1878469433.USD","SG9999015986.USD","LU0157215616.USD","LU2238339852.HKD","LU2357305700.SGD","AMPS","LU0466842654.USD","LU1914381329.SGD","HUMA","LU2361044949.HKD","IONS","LU0094547139.USD","BK4555","VKTX","WGO"],"gpt_icon":1},{"id":"2492414611","title":"BUZZ--美国股票走势-联邦快递、礼来公司、Aadi 生物科学公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2492414611","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492414611?lang=zh_cn&edition=full","pubTime":"2024-12-20 20:04","pubTimestamp":1734696255,"startTime":"0","endTime":"0","summary":"** 联邦快递  ： BUZZ - 分析师认为联邦快递分拆货运卡车部门是有益的；上调PT   ** Eli Lilly and Co   : BUZZ - 诺和诺德的下一代肥胖症药物在研究中表现不佳，导致价格上涨   ** Humacyte   : BUZZ - 因血管植入物获得 FDA 批准而上涨逾 40   ** 美国钢铁  : BUZZ - 在预测第四季度意外亏损后下跌   ** Aadi Bioscience   : BUZZ - 因癌症药物许可协议而上涨   ** Viking Therapeutics   ：** Structure Therapeutics   ：** Altimmune   ：** 安进  ： BUZZ - 诺和诺德的肥胖症药物在研究中表现不佳，减肥药开发商获得收益   ** Ionis Pharmaceuticals   : BUZZ - 因FDA批准遗传性疾病药物而上涨","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868836591.USD","LU2602419157.SGD","X","IE00B1BXHZ80.USD","SG9999017495.SGD","LU0114720955.EUR","LU0079474960.USD","LU0122379950.USD","LU0742534661.SGD","LU0471298694.HKD","LU1061106388.HKD","LU0882574139.USD","LU0058720904.USD","LU0238689110.USD","IE00BJT1NW94.SGD","LU0820561909.HKD","LU0310800965.SGD","LU0320765992.SGD","LU0354030511.USD","LU1868837300.USD","AADI","LU2360106947.USD","LU0466842654.USD","SG9999001440.SGD","BK4006","LU2265009873.SGD","BK4588","LU1878469433.USD","LLY","LU1035775433.USD","LU1988902786.USD","AMGN","IE00B4R5TH58.HKD","BK4520","LU1814569148.SGD","HUMA","BK4585","GPCR","SG9999018857.SGD","BK4599","VKTX","LU1551013425.SGD","IONS","LU1093756325.SGD","FDX","ALT","LU1064131342.USD","LU0354030438.USD","LU0289739699.SGD","LU2089984988.USD"],"gpt_icon":1},{"id":"2492411484","title":"BUZZ-Ionis Pharma 因 FDA 批准遗传性疾病药物而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2492411484","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492411484?lang=zh_cn&edition=full","pubTime":"2024-12-20 19:54","pubTimestamp":1734695655,"startTime":"0","endTime":"0","summary":"12月20日 -  ** 制药公司Ionis Pharmaceuticals IONS.O 的股价盘前上涨约8%，至38.43美元。** 周四，IONS称美国食品和药物管理局批准了  公司的遗传疾病药物olezarsen，用于治疗家族性乳糜微粒血症综合征 ** FCS 是一种阻止人体分解脂肪的疾病，其特征是甘油三酯水平极高。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nL4S3NL0QG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IONS","BK4139"],"gpt_icon":0},{"id":"2492217467","title":"Ionis Pharmaceuticals(IONS.US)旗下罕见病药物Olezarsen获FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2492217467","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492217467?lang=zh_cn&edition=full","pubTime":"2024-12-20 15:28","pubTimestamp":1734679712,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，美国食品药品监督管理局已批准Ionis Pharmaceuticals旗下治疗罕见遗传疾病的药物Olezarsen，这是该公司首个全资拥有的药物。Olezarsen被批准作为一种附加治疗，以降低成人患者的甘油三酯水平。受此消息提振，Ionis Pharmaceuticals周四美股盘后涨近7%。Ionis Pharmaceuticals表示，将在投资者电话会议上宣布该药物定价的细节。Kostas Biliouris预估，Ionis Pharmaceuticals旗下FCS治疗药物的销售额最高达3.41亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1227552.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Ionis Pharmaceuticals(IONS.US)旗下罕见病药物Olezarsen获FDA批准","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","IONS"],"gpt_icon":0},{"id":"2492772487","title":"美国 FDA 批准 Ionis 制药公司的遗传性疾病药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2492772487","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492772487?lang=zh_cn&edition=full","pubTime":"2024-12-20 06:08","pubTimestamp":1734646120,"startTime":"0","endTime":"0","summary":"美国 FDA 批准 Ionis 制药公司的遗传性疾病药物路透12月19日 - 美国食品和药物管理局的网站周四显示，美国食品和药物管理局已经批准了Ionis Pharmaceuticals公司用于治疗一种罕见遗传性疾病的IONS.O药物，这也是该公司的首个独资药物。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nL4T3NK1S8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IONS"],"gpt_icon":0},{"id":"2492464807","title":"Ionis Pharmaceuticals, Inc.盘中异动 股价大涨5.10%报38.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492464807","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492464807?lang=zh_cn&edition=full","pubTime":"2024-12-17 02:15","pubTimestamp":1734372915,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日02时15分，Ionis Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.10%。Ionis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.85%。Ionis Pharmaceuticals, Inc.公司简介：Ionis Pharmaceuticals Inc是研发新型药物反义技术的领头研发者。Ionis和阿斯利康将于2024年推出多发性神经病药物Wainua。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217021515984c7457&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217021515984c7457&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IONS"],"gpt_icon":0},{"id":"2489561482","title":"Ionis Pharmaceuticals, Inc.盘中异动 快速上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489561482","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489561482?lang=zh_cn&edition=full","pubTime":"2024-12-07 01:24","pubTimestamp":1733505853,"startTime":"0","endTime":"0","summary":"北京时间2024年12月07日01时24分，Ionis Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.03%。Ionis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。Ionis Pharmaceuticals, Inc.公司简介：Ionis Pharmaceuticals Inc是研发新型药物反义技术的领头研发者。Ionis和阿斯利康将于2024年推出多发性神经病药物Wainua。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241207012413ab632914&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241207012413ab632914&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IONS","BK4139"],"gpt_icon":0},{"id":"2486038876","title":"Ionis Pharmaceuticals, Inc.盘中异动 早盘快速拉升5.00%报35.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486038876","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486038876?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:44","pubTimestamp":1732545889,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时44分，Ionis Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.00%。Ionis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.72%。其相关个股中，Bridgebio Pharma, Inc.、Scholar Rock Holding Corporation、Mural Oncology Plc涨幅较大，Cognition Therapeutics, Inc.、木薯科学、Citius Pharmaceuticals, Inc.较为活跃，换手率分别为92.06%、74.29%、46.90%，振幅较大的相关个股有Kodiak Sciences Inc、Jasper Therapeutics, Inc.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为106.46%、106.21%、61.31%。Ionis Pharmaceuticals, Inc.公司简介：Ionis Pharmaceuticals Inc是研发新型药物反义技术的领头研发者。Ionis和阿斯利康将于2024年推出多发性神经病药物Wainua。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522445098e446ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522445098e446ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IONS","BK4139"],"gpt_icon":0},{"id":"2485428977","title":"Ionis Pharmaceuticals, Inc.盘中异动 临近收盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485428977","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485428977?lang=zh_cn&edition=full","pubTime":"2024-11-22 04:51","pubTimestamp":1732222315,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日04时51分，Ionis Pharmaceuticals, Inc.股票出现异动，股价大幅下跌5.00%。Ionis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。其相关个股中，Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Briacell Therapeutics Corp.、奥麦罗制药涨幅较大，Biodexa Pharmaceuticals Plc、Conduit Pharmaceuticals Inc.、Tff Pharmaceuticals, Inc.较为活跃，换手率分别为993.23%、551.49%、416.35%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Biodexa Pharmaceuticals Plc，振幅分别为162.20%、87.47%、84.16%。Ionis Pharmaceuticals, Inc.公司简介：Ionis Pharmaceuticals Inc是研发新型药物反义技术的领头研发者。Ionis和阿斯利康将于2024年推出多发性神经病药物Wainua。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122045156971a7f48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122045156971a7f48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IONS"],"gpt_icon":0},{"id":"2485122753","title":"Ionis Pharmaceuticals, Inc.盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485122753","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485122753?lang=zh_cn&edition=full","pubTime":"2024-11-21 03:57","pubTimestamp":1732132643,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日03时57分，Ionis Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.01%。Ionis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。其相关个股中，Forte Biosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Exicure, Inc.涨幅较大，Forte Biosciences, Inc.、Silexion Therapeutics Corp、Exicure, Inc.较为活跃，换手率分别为1890.48%、1337.38%、1016.03%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Forte Biosciences, Inc.、Exicure, Inc.，振幅分别为185.64%、169.09%、136.94%。Ionis Pharmaceuticals, Inc.公司简介：Ionis Pharmaceuticals Inc是研发新型药物反义技术的领头研发者。Ionis和阿斯利康将于2024年推出多发性神经病药物Wainua。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112103572398e43cd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112103572398e43cd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IONS"],"gpt_icon":0},{"id":"2483062083","title":"Ionis Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483062083","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483062083?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:05","pubTimestamp":1731686754,"startTime":"0","endTime":"0","summary":"北京时间2024年11月16日00时05分，Ionis Pharmaceuticals, Inc.股票出现异动，股价快速下跌5.00%。Ionis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为3.62%。Ionis Pharmaceuticals, Inc.公司简介：Ionis Pharmaceuticals Inc是研发新型药物反义技术的领头研发者。Ionis和阿斯利康将于2024年推出多发性神经病药物Wainua。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000554a23b8bed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000554a23b8bed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IONS"],"gpt_icon":0},{"id":"2483385828","title":"Ionis Pharmaceuticals, Inc.2024财年第三财季实现净利润-1.40亿美元，同比增加4.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483385828","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483385828?lang=zh_cn&edition=full","pubTime":"2024-11-15 00:00","pubTimestamp":1731600030,"startTime":"0","endTime":"0","summary":"11月15日，Ionis Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第三财季净利润为-1.40亿美元，同比增加4.76%；其中营业收入为1.34亿美元，同比减少6.94%，每股基本收益为-0.95美元。机构评级：截至2024年11月15日，当前有21家机构对Ionis Pharmaceuticals, Inc.目标价做出预测，其中目标均价为61.00美元，其中最低目标价为37.00美元，最高目标价为77.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115000040a237ff7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115000040a237ff7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IONS"],"gpt_icon":0},{"id":"2466468453","title":"BUZZ--美国股票走势-Arrowhead Pharma、波音公司、Centessa Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2466468453","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466468453?lang=zh_cn&edition=full","pubTime":"2024-09-10 23:59","pubTimestamp":1725983967,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      9月10日 - 标普500指数和纳斯达克指数周二上涨，多数大盘股上涨，目前市场焦点转向本周晚些时候的关键通胀数据，该数据可能进一步明确美联储9月18日降息的预期幅度。美东时间11:34，道琼斯工业平均指数  下跌0.5%，报40,639.63点。标普500指数  上涨0.17%，报5480.53点；纳斯达克综合指数  上涨0.41%，报16954.15点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALIM","CLF",".DJI","CRH","WYNN","PSQ","RLAY","ASO",".IXIC","KGS","SQQQ","SDOW","XOM","COP","NEM","CAH","DOG","UDOW","MNQmain","DDM","F","LU","PSX","NQmain","VRDN","HES","SIRI","AU","QID",".SPX","BA","CVX","FCX","MCK","COR","BKR","RTX","GE","GM","HPE","DJX","ARWR","IONS","RBRK","DXD"],"gpt_icon":1},{"id":"2466453812","title":"BUZZ--美国股票走势-惠普企业、富国银行、Rubrik","url":"https://stock-news.laohu8.com/highlight/detail?id=2466453812","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466453812?lang=zh_cn&edition=full","pubTime":"2024-09-10 21:18","pubTimestamp":1725974312,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      9月10日 - 在本周晚些时候的关键通胀数据公布之前，华尔街周二将高开，这些数据可能会巩固对美联储预计在9月18日降息幅度的押注。美东时间9:07，道指电子盘  上涨0.11%，报40929点；标普500指数电子盘  上涨0.31%，报5496.5点；纳斯达克100指数电子盘  上涨0.36%，报18759点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","LU0208291251.USD","IE0009356076.USD","CLF","HPQ","LU0496367417.USD","LU1883866441.USD","BK4207","CRH","IE00BFSS7M15.SGD","ASO","KGS","LU1064131342.USD","LU0630314457.HKD","ORCL","WFC","NEM","LU1992135399.USD","LU0198837287.USD","LU0320765489.SGD","IE00BWXC8680.SGD","LU0354030511.USD","LU0640476718.USD","LU2237438978.USD","F","BK4566","LU0498741890.SGD","IE00B19Z9Z06.USD","VRDN","LU0162691827.USD","AU","FCX","BK4206","BK4561","RTX","GE","GM","LU0029864427.USD","LU0354030438.USD","LU0456854461.SGD","HPE","IE00B19Z9P08.USD","IONS","LU1880398471.USD","LU0052756011.USD","LU0708994859.HKD","LU0965509010.AUD","RBRK","LU0820562030.AUD"],"gpt_icon":1},{"id":"2466430471","title":"BUZZ-Ionis Pharma 因计划发行 5 亿美元股票而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2466430471","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466430471?lang=zh_cn&edition=full","pubTime":"2024-09-10 05:01","pubTimestamp":1725915686,"startTime":"0","endTime":"0","summary":"    9月9日 - ** Ionis Pharmaceuticals    股价盘后下跌 7.6%，报 44.64 美元，该公司正寻求股票融资** 该公司宣布发行 5 亿美元股票 ，摩根士丹利和高盛担任联席账簿管理人** 该公司计划将募集资金净额用于独立的商业启动、后期临床/早期管线项目、研发以及其他一般用途。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","BK4588","LU1720051108.HKD","BK4581","LU1989772923.USD","LU0314104364.USD","IE00BZ1G4Q59.USD","BK4533","BK4139","LU1720051017.SGD","LU1074936037.SGD","LU1668664300.SGD","BK4585","LU0098860793.USD","BK4127","LU0234570918.USD","LU1989772840.SGD","IE00B19Z9Z06.USD","LU1162221912.USD","LU0267386448.USD","BIIB","LU0320765646.SGD","LU2357305700.SGD","LU0109394709.USD","BK4532","LU1548497426.USD","LU0106831901.USD","LU0225283273.USD","LU1363072403.SGD","IE00BKVL7J92.USD","IE00B894F039.SGD","LU0971096721.USD","IE00B19Z9P08.USD","BK4534","IONS","LU0320765992.SGD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2462395986","title":"美国研究综述-First BanCorp、Kellanova、Popular","url":"https://stock-news.laohu8.com/highlight/detail?id=2462395986","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462395986?lang=zh_cn&edition=full","pubTime":"2024-08-26 15:04","pubTimestamp":1724655889,"startTime":"0","endTime":"0","summary":"    路透8月26日 - 华尔街证券分析师周一调整了对 First BanCorp、Kellanova 和 Popular 等几家美国上市公司的评级和目标价。要闻             * First BanCorp   ：Piper Sandler 继续覆盖，给予中性评级             * Kellanova   ：D.A.戴维森将其评级从 \"买入 \"下调至 \"中性\"。* Popular Inc   ：Piper Sandler 将其评级定为 \"增持\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALNY","CTRE","MAA","LU1861558580.USD","FBPRO","IONS","LU1974910355.USD","VICI","LU2023250504.SGD","CPT","FBPRM","VTR","TDOC","BK4211","FBP","HCAT","BK4561","LANC","FBPRL","BPOP","OHI","BK4504","UDR","BK4588","XRAY","FBPRN","BK4225","LU1223082196.USD","BK4585","BJ","BK4212","GFI","LU1223083913.SGD","WELL","OFG","BK4155","BK4198","ESS","BK4115","BPOPM","ALGN","BK4167","BPOPN","FBPRP","RNA","BK4548","K","BK4567","IHS","BK4505"],"gpt_icon":0},{"id":"2458516018","title":"Ionis Pharmaceuticals, Inc.2024财年第二财季实现净利润-66.27百万美元，同比增加22.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458516018","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458516018?lang=zh_cn&edition=full","pubTime":"2024-08-10 00:17","pubTimestamp":1723220250,"startTime":"0","endTime":"0","summary":"8月10日，Ionis Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第二财季净利润为-66.27百万美元，同比增加22.30%；其中营业收入为2.25亿美元，同比增加19.68%，每股基本收益为-0.45美元。机构评级：截至2024年8月10日，当前有22家机构对Ionis Pharmaceuticals, Inc.目标价做出预测，其中目标均价为61.77美元，其中最低目标价为37.00美元，最高目标价为82.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408100017419f1e1054&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408100017419f1e1054&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IONS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ionispharma.com","stockEarnings":[{"period":"1week","weight":0.0079},{"period":"1month","weight":0.0003},{"period":"3month","weight":-0.1209},{"period":"6month","weight":-0.2465},{"period":"1year","weight":-0.2889},{"period":"ytd","weight":-0.2902}],"compareEarnings":[{"period":"1week","weight":0.0065},{"period":"1month","weight":-0.0064},{"period":"3month","weight":0.0412},{"period":"6month","weight":0.0933},{"period":"1year","weight":0.2482},{"period":"ytd","weight":0.2518}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"伊奥尼斯制药公司在反义药物发明和开发上处于行业领先地位，利用新药研发平台，公司研发了大量的一流药品。反义技术在基因学和药物之间打开了一条通道。凭着公司高效多产的药物研发平台，公司可以用反义药物拓展自身及其合作伙伴的药物种类，满足大量的药物需求。公司的策略是做公司最擅长的事--寻找独特的反义药物并开发这些药物，使其成为关键的临床值转折点。公司发明并进行新药早期研究，然后将药物授权给合作伙伴。公司通过把药物交给领先的制药公司进行后期开发来实现药物的最大价值，如Biogen Idec公司、百时美施贵宝公司、 健赞公司、赛诺菲公司、葛兰素史克公司和礼来制药公司。 该公司的旗舰产品 KYNAMRO，正朝着市场上家族性高胆固醇血症患者迈进。 该公司于1989年在美国加州成立。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":-0.019969},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.021252},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.021038},{"month":4,"riseRate":0.333333,"avgChangeRate":0.018116},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.065195},{"month":6,"riseRate":0.777778,"avgChangeRate":0.046176},{"month":7,"riseRate":0.777778,"avgChangeRate":0.0362},{"month":8,"riseRate":0.555556,"avgChangeRate":0.014474},{"month":9,"riseRate":0.444444,"avgChangeRate":-0.002333},{"month":10,"riseRate":0.111111,"avgChangeRate":-0.044503},{"month":11,"riseRate":0.555556,"avgChangeRate":0.09545},{"month":12,"riseRate":0.555556,"avgChangeRate":0.010254}],"exchange":"NASDAQ","name":"Ionis Pharmaceuticals, Inc","nameEN":"Ionis Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ionis Pharmaceuticals, Inc(IONS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ionis Pharmaceuticals, Inc(IONS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ionis Pharmaceuticals, Inc,IONS,Ionis Pharmaceuticals, Inc股票,Ionis Pharmaceuticals, Inc股票老虎,Ionis Pharmaceuticals, Inc股票老虎国际,Ionis Pharmaceuticals, Inc行情,Ionis Pharmaceuticals, Inc股票行情,Ionis Pharmaceuticals, Inc股价,Ionis Pharmaceuticals, Inc股市,Ionis Pharmaceuticals, Inc股票价格,Ionis Pharmaceuticals, Inc股票交易,Ionis Pharmaceuticals, Inc股票购买,Ionis Pharmaceuticals, Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ionis Pharmaceuticals, Inc(IONS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ionis Pharmaceuticals, Inc(IONS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}